Clinical Trial Update: IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial IRELAnD evaluating early low-dose aspirin in pregestational diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Royal College of Surgeons, Ireland | Conditions: Pre-Gestational Diabetes | Phase 3 | Status: COMPLETED